DRW Securities’s Cardlytics CDLX Stock Holding History

DRW Securities’s Portfolio CDLX Stock Details CDLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,158	Closed	-$19K	–	1322
2025 Q2	$19K	Buy	+1,158	New	+$20K	﹤0.01%	1064

Other funds holding CDLX

CIP

CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

KGAMU

KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

WPM

Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return

QOP

Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

DRW Securities's CDLX Position: Q3 2025 in Review

DRW Securities sold out of Cardlytics (CDLX) in Q3 2025, closing a stake of 1,158 shares — an estimated $19K sold.

DRW Securities first reported a position in CDLX in Q2 2025 and held it in 1 quarter. The position peaked at $19K in Q2 2025. 81 funds tracked by Wall St. Rank hold CDLX as of Q3 2025.

DRW Securities reported no remaining Cardlytics position as of Q3 2025 after selling out during the quarter.
DRW Securities sold 1,158 Cardlytics shares in Q3 2025, an estimated $19K.
DRW Securities first reported a position in Cardlytics in Q2 2025 and held it in 1 quarter.
DRW Securities's Cardlytics position peaked at $19K in Q2 2025.
81 funds tracked by Wall St. Rank held Cardlytics as of Q3 2025.

Based on DRW Securities's 13F filing for Q3 2025, filed 14 Nov 2025.